| Estimating the reference incremental cost-effectiveness ratio for the Australian health system LC Edney, H Haji Ali Afzali, TC Cheng, J Karnon Pharmacoeconomics 36, 239-252, 2018 | 191 | 2018 |
| Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis B Wang, R Santoreneos, L Giles, HHA Afzali, H Marshall Vaccine 37 (21), 2768-2782, 2019 | 146 | 2019 |
| Efficiency measurement for hospitals owned by the Iranian social security organisation H Hajialiafzali, JR Moss, MA Mahmood Journal of medical systems 31, 166-172, 2007 | 87 | 2007 |
| When to use discrete event simulation (DES) for the economic evaluation of health technologies? A review and critique of the costs and benefits of DES J Karnon, H Haji Ali Afzali Pharmacoeconomics 32, 547-558, 2014 | 82 | 2014 |
| A critical review of model-based economic studies of depression: modelling techniques, model structure and data sources. HHA Afzali, J Karnon, J Gray Pharmacoeconomics 30 (6), 2012 | 39 | 2012 |
| The inpatient costs and hospital service use associated with invasive meningococcal disease in South Australian children B Wang, HHA Afzali, H Marshall Vaccine 32 (37), 4791-4798, 2014 | 36 | 2014 |
| Improving the accuracy and comparability of model-based economic evaluations of health technologies for reimbursement decisions: a methodological framework for the development … HHA Afzali, J Karnon, T Merlin Medical Decision Making 33 (3), 325-332, 2013 | 34 | 2013 |
| The clinical burden and predictors of sequelae following invasive meningococcal disease in Australian children B Wang, M Clarke, N Thomas, S Howell, HHA Afzali, H Marshall The Pediatric infectious disease journal 33 (3), 316-318, 2014 | 32 | 2014 |
| A conceptual framework for selecting the most appropriate variables for measuring hospital efficiency with a focus on Iranian public hospitals HHA Afzali, JR Moss, MA Mahmood Health Services Management Research 22 (2), 81-91, 2009 | 32 | 2009 |
| Community, parental and adolescent awareness and knowledge of meningococcal disease B Wang, M Clarke, HHA Afzali, H Marshall Vaccine 32 (18), 2042-2049, 2014 | 31 | 2014 |
| Exploring structural uncertainty in model-based economic evaluations H Haji Ali Afzali, J Karnon Pharmacoeconomics 33, 435-443, 2015 | 29 | 2015 |
| Practice nurse involvement in general practice clinical care: policy and funding issues need resolution HHA Afzali, J Karnon, J Beilby, J Gray, C Holton, D Banham Australian Health Review 38 (3), 301-305, 2014 | 25 | 2014 |
| Mortality reductions from marginal increases in public spending on health LC Edney, HHA Afzali, TC Cheng, J Karnon Health Policy 122 (8), 892-899, 2018 | 24 | 2018 |
| Costs of invasive meningococcal disease: a global systematic review B Wang, R Santoreneos, H Afzali, L Giles, H Marshall PharmacoEconomics 36, 1201-1222, 2018 | 23 | 2018 |
| Model performance evaluation (validation and calibration) in model-based studies of therapeutic interventions for cardiovascular diseases: a review and suggested reporting … H Haji Ali Afzali, J Gray, J Karnon Applied health economics and health policy 11, 85-93, 2013 | 23 | 2013 |
| Adolescent confidence in immunisation: assessing and comparing attitudes of adolescents and adults B Wang, L Giles, HHA Afzali, M Clarke, J Ratcliffe, G Chen, H Marshall Vaccine 34 (46), 5595-5603, 2016 | 22 | 2016 |
| Adolescent values for immunisation programs in Australia: a discrete choice experiment B Wang, G Chen, J Ratcliffe, HHA Afzali, L Giles, H Marshall PLoS One 12 (7), e0181073, 2017 | 21 | 2017 |
| Addressing the challenge for well informed and consistent reimbursement decisions HHA Afzali, J Karnon Pharmacoeconomics 29 (10), 823, 2011 | 21 | 2011 |
| A proposed model for economic evaluations of major depressive disorder H Haji Ali Afzali, J Karnon, J Gray The European Journal of Health Economics 13, 501-510, 2012 | 20 | 2012 |
| Governments need better guidance to maximise value for money: the case of Australia’s Pharmaceutical Benefits Advisory Committee D Carter, A Vogan, H Haji Ali Afzali Applied health economics and health policy 14, 401-407, 2016 | 18 | 2016 |
